Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-125839
Filing Date
2016-06-03
Accepted
2016-06-03 19:12:25
Documents
1
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5452
  Complete submission text file 0001209191-16-125839.txt   6946
Mailing Address 689 5TH AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address
Kazam Joshua A (Reporting) CIK: 0001221355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36508 | Film No.: 161697167

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)